Association of K-ras mutations with p16 methylation in human colon cancer

作者: Rong J. Guan , Yineng Fu , Peter R. Holt , Arthur B. Pardee

DOI: 10.1016/S0016-5085(99)70009-0

关键词:

摘要: Abstract Background & Aims: K- ras mutations are early genetic changes in colon cancer. p16, a tumor-suppressor gene, is inactivated neoplasms by mutation, deletion, or methylation. The aims of this study were to determine p16 methylation status and its possible association with human Methods: DNA isolated from 8 cancer cell lines 41 microdissected tissue samples was analyzed. determined using two analytical methods. level expression reverse-transcription polymerase chain reaction Northern blot. sequence analysis. methyltransferase activity microassay. Parental –transformed IEC-18 cells used the potential between Results: Methylated found 100% lines, 55% cancers, 54% adenomas, 25% transitional mucosa but not normal colonic epithelium. Forty-five percent cancers 38% adenomas showed both Of 11 10 specimens methylated p16. In contrast, 13 wild-type ras, only 3 ( P = 0.001). Stable transformation increased activity, suppressed Treatment inhibitor (azadeoxycytidine) resulted reexpression cells, suggesting that Conclusions: occurs frequently closely associated mutations. GASTROENTEROLOGY 1999;116:1063-1071

参考文章(46)
Stefan W. Faulkner, Don A. Leigh, Universal amplification of DNA isolated from small regions of paraffin-embedded, formalin-fixed tissue BioTechniques. ,vol. 24, pp. 47- 50 ,(1998) , 10.2144/98241BM08
Carlos Caldas, Stephan A Hahn, Ralph H Hruban, Mark S Redston, Charles J Yeo, Scott E Kern, None, Detection of K-ras Mutations in the Stool of Patients with Pancreatic Adenocarcinoma and Pancreatic Ductal Hyperplasia Cancer Research. ,vol. 54, pp. 3568- 3573 ,(1994)
T L Kautiainen, P A Jones, DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. Journal of Biological Chemistry. ,vol. 261, pp. 1594- 1598 ,(1986) , 10.1016/S0021-9258(17)35981-1
William B. Isaacs, Stephen B. Baylin, Nancy E. Davidson, Jeremy R. Graff, James G. Herman, Rena G. Lapidus, Paula M. Pitha, Rosa Xu, Hemi Chopra, David F. Jarrard, E-Cadherin Expression Is Silenced by DNA Hypermethylation in Human Breast and Prostate Carcinomas Cancer Research. ,vol. 55, pp. 5195- 5199 ,(1995)
Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Paula M. Vertino, Jean-Pierre Issa, ALTERATIONS IN DNA METHYLATION : A FUNDAMENTAL ASPECT OF NEOPLASIA Advances in Cancer Research. ,vol. 72, pp. 141- 196 ,(1998) , 10.1016/S0065-230X(08)60702-2
C L Hsieh, Dependence of transcriptional repression on CpG methylation density. Molecular and Cellular Biology. ,vol. 14, pp. 5487- 5494 ,(1994) , 10.1128/MCB.14.8.5487
Robert A. Weinberg, Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Research. ,vol. 49, pp. 3713- 3721 ,(1989)
Stephen B. Baylin, James G. Herman, Sanna K. Myöhänen, Hypermethylation Can Selectively Silence Individual p16ink4A Alleles in Neoplasia Cancer Research. ,vol. 58, pp. 591- 593 ,(1998)
S. Goelz, B Vogelstein, Hamilton, A. Feinberg, Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. ,vol. 228, pp. 187- 190 ,(1985) , 10.1126/SCIENCE.2579435
M. Frommer, L. E. McDonald, D. S. Millar, C. M. Collis, F. Watt, G. W. Grigg, P. L. Molloy, C. L. Paul, A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 1827- 1831 ,(1992) , 10.1073/PNAS.89.5.1827